NexLife review

Take a quarter dose here and the bill does not change — NexLife says so under the price and again in its FAQ, so at least you are not left to work it out. Two things it does better than most: the month-to-month rate is an ordinary row in the same table as the three prepay plans rather than hidden behind them, and the rungs sit close enough together that you are not being pushed hard into paying for a year at once. It also names five candidate pharmacies instead of gesturing at partners. Two things will cost you. The homepage advertises a monthly figure that matches neither the monthly rate nor the twelve-month rate on the product page, so budget from the table and not from the banner. And the money-back promise is written around "up to 10%", a condition any weight loss at all satisfies — read it as marketing, not as a guarantee.

Vs median

$4/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

NexLife dispenses through a Network facility. No bloodwork is required before you start. A clinician review is included in the price.

NexLife sells compounded semaglutide and compounded tirzepatide on monthly and prepaid plans, stating its flat-dose promise directly under the price and again in its FAQ. It names five candidate compounding pharmacies — Absolute, Hallandale, Red Rock, Empower and Strive — but says fulfillment "may be supported by" those "or other qualified 503A compounding pharmacies", so the compounder is not assigned in advance. It itemizes a nutrition plan, a coaching call and the provider review as included added value.

THE SAME PRICE APPLIES AT EVERY DOSE, so a quarter dose is billed at the full-dose rate and the difference is drug you paid for and did not inject

• THE HOMEPAGE FIGURE MATCHES NOTHING ON THE PRODUCT PAGE. "As low as $155 /mo*" is neither the $165 monthly rate nor the $145 twelve-month rate, and the page title leads with the twelve-month figure instead
• The money-back promise reads "Follow the plan, lose up to 10% in 6 months or get your money back" — "up to 10%" makes the condition unfalsifiable as written, since any loss at all is "up to" 10%
• "$377 in added value included at no extra cost" is itemized as a $99 nutrition plan, a $79 coaching call and a $199 provider review — but the provider review is a prerequisite for a prescription, not a bonus
• "NexLife is a LegitScript-certified telehealth platform" with no seal ID shown
• The specific compounding pharmacy is not assigned in advance — five are named as possibilities, alongside "or other qualified 503A compounding pharmacies"
• No list of states served is published, and no week count sits behind the monthly figure
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

NexLife is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan